Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1994-09-14
1997-02-11
Scheiner, Toni R.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
435 5, 435 72, 435 724, 5303873, 5303881, 5303882, 53038822, G01N 3353, C07K 1600, A61K 39395
Patent
active
056018193
ABSTRACT:
Bispecific antibodies can be used to alter the ratio and proliferation of T cell subsets, to selectively target cells that coexpress two different surface antigens such as the activated T cell subsets, or to block the cytolytic function of specific T cell subsets.
REFERENCES:
patent: 4361549 (1982-11-01), Kung et al.
patent: 4361550 (1982-11-01), Kung et al.
patent: 4363799 (1982-12-01), Kung et al.
patent: 4364932 (1982-12-01), Kung et al.
patent: 4364933 (1982-12-01), Kung et al.
patent: 4364934 (1982-12-01), Kung et al.
patent: 4364935 (1982-12-01), Kung et al.
patent: 4364936 (1982-12-01), Kung et al.
patent: 4364937 (1982-12-01), Kung et al.
patent: 4381295 (1983-04-01), Kung et al.
patent: 4542225 (1985-09-01), Blattler et al.
patent: 4925648 (1990-05-01), Hansen et al.
Allison et al., "Structure, Function, and Serology of the T-Cell Antigen Receptor Complex," Ann. Rev. Immunol. 5:503-40 (1987).
Anderson et al., "Cross-Linking of T3 (CD3) with T4 (CD4) Enhances the Proliferation of Resting T Lymphocytes," The Journal of Immunol. 139:678-682 (1987).
Bank et al., "Perturbation of the T4 Molecule Transmits a Negative Signal to T Cells," J. Exp. Med. 162:1294-1303 (1985).
Bernard et al., "A Novel Human Leukocyte Differentiation Antigen," The Journal of Immunol. 132:2338-2344 (1984).
Emmrich et al., "Synergism in the Activaton of Human CD8 T Cells by Cross-Linking the T-Cell Receptor Complex with the CDS Differentiation Antigen," Proc. Natl. Acad. Sci. USA 83:8298-8302 (1986).
Fleischer et al., "Function of the CD4 and CD8 Molecules on Human Cytotoxic T Lymphocytes: Regulation of T Cell Triggering," The Journal of Immunol. 136:1625-1628 (1986).
Kaye et al., "The Fab Fragment of a Directly Activating Monoclonal Antibody . . . " J. Exp. Med. 159:1397-1412 (1984).
Kipps et al., "Importance of Immunoglobulin Isotype in Human Antibody-Dependent, Cell-Mediated Cytotoxicity Directed by Murine Monoclonal Antibodies," The Journal of Exp. Med. 161:1-17 (1985).
Landau et al., "The Envelope Glycoprotein of the Human Immunodeficiency Virus Binds to the Immunoglobulin-Like Domain of CD4," Nature 334:159-162 (1988).
Lazarovits et al., "Lymphocyte Activation Antigens," J. Immunol. 133:1857-1862 (1984).
Leontsini et al., "Physical and Functional Association of the T Cell Receptor and the T3 Molecular Complex on Cytotoxic T Cells Clones . . . " Cellular Immunology 102:21-32 (1986).
Mason et al., "Effector Mechanisms in Allograft Rejection," Ann. Rev. Immunol. 4:119-45 (1986).
McMichael et al., Leucocyte Typing III, Springer-Verlag, Heidelberg (1987).
Milstein et al., "Hybrid Hybridomas and Their Use in Immunohistochemistry," Nature 35:537-40 (1983).
Moretta et al., "Clonal Heterogeneity in the Requirement for T3, T4, and T8 Molecules in Human Cytolytic T Lymphocyte Function," J. Exp. Med. 159:921-934 (1984).
Morimoto et al., "The Isolation and Characterization of the Human Suppressor Inducer T Cell Subset," J. of Immunol. 134:1508-15 (1985).
Morimoto et al., "The Isolation and Characterization of the Human Helper Inducer T Cell Subset," J. of Immunol. 134:3762-69 (1985).
Parham, Peter, "In Vitro Production of a Hybrid Monoclonal Antibody that Preferentially Binds to Cells that Express Both HLA-A2 and HLA-B", Human Immunology 12:213-21 (1985).
Perez et al., "Specific Targeting of Human Peripheral Blood T Cells by Heteroaggregates Containing Anti-T3 Crosslinked to Anti-Target Cell Antibodies," J. of Exp. Med. 163:166-17 (1986).
Reinherz et al., "Subpopulations of the T4+ Inducer T Cell Subset in Man," J. of Immunol. 126:67-70 (1981).
Sattentau et al., "Epitopes of the CD4 Antigen and HIV Infection," Science 234:1120-23 (1986).
Shaw et al., "Susceptibility of Cytotoxic T Lymphocyte (CTL) Clones to Inhibiton by Anti-T3 and Anti-T4 . . . " J. of Immunol. 134:3019-26 (1985).
Staerz, "Hybrid Hybridoma Producing a Bispecific Monoclonal Antibody that Can Focus Effector T-Cell Activity," Proc. Natl. Acad. Sci., 83:1453-57 (1986).
Terasaki et al., "Microdroplet Testing for HLA-A, -B, -C and -D Antigens," A.J.C.P. 69:103-20 (1978).
Van Wauwe et la., "OKT3: A Monoclonal Anti-Human T Lymphocyte Antibody with Potent Mitogenic Properties," J. of Immunol. 124:2708-13 (1980).
Walker et al., "Activation of T Cells by Cross-Linking an Anti-CD3 Antibody with a Second Anti-T Cell Antibody: Mechanism and Subset-Specific Activation," Eur. J. Immunol. 17:873-80 (1987).
Wong et al., "The Journal of Allergy and Clinical Immunology", vol. 77, No. 1, Part 2, p. 229, Abstract 434, Jan. 1986.
Wong et al., "Bi-Specific Monoclonal Antibodies: Selective Binding and Complement Fixation to Cells that Express Two Different Surface Antigens," J. of Immunol. 139:1369-74 (1987).
Wong et al., The FASEB Journal, vol. 2, No. 6, Abstract 8898, Mar. 25, 1988 .
Colvin Robert B.
Wong Johnson T.
Scheiner Toni R.
The General Hospital Corporation
LandOfFree
Bispecific antibodies for selective immune regulation and for se does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bispecific antibodies for selective immune regulation and for se, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific antibodies for selective immune regulation and for se will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339719